EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.4.15.1 | Cl- | required | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.15.1 | captopril | - |
Homo sapiens | |
3.4.15.1 | EDTA | - |
Homo sapiens | |
3.4.15.1 | snake venom peptide | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.15.1 | 0.6 | - |
benzoyl-Gly-Phe-Arg | - |
Homo sapiens | |
3.4.15.1 | 1.3 | - |
benzoyl-Gly-His-Leu | - |
Homo sapiens | |
3.4.15.1 | 6.2 | - |
benzoyl-Gly-Gly-Gly | - |
Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.15.1 | 155000 | - |
enzyme from serum, sucrose density gradient centrifugation | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.15.1 | Homo sapiens | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.4.15.1 | side-chain modification | enzyme from lung and kidney contains similar amounts of N-acetylglucosamine, mannose, galactose and fucose. The lung enzyme contains significantly more sialic acid | Homo sapiens |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.15.1 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.15.1 | kidney | - |
Homo sapiens | - |
3.4.15.1 | lung | - |
Homo sapiens | - |
3.4.15.1 | serum | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.15.1 | 32 | - |
- |
Homo sapiens |
EC Number | Storage Stability | Organism |
---|---|---|
3.4.15.1 | -20°C, pH 7.0, 0.01 M KH2PO4/K2HPO4, 0.5 M NaCl, stable for several months | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.15.1 | angiotensin I + H2O | - |
Homo sapiens | angiotensin II + His-Leu | - |
? | |
3.4.15.1 | benzoyl-Gly-Gly-Gly + H2O | - |
Homo sapiens | benzoyl-Gly + Gly-Gly | - |
? | |
3.4.15.1 | benzoyl-Gly-His-Leu + H2O | - |
Homo sapiens | benzoyl-Gly + His-Leu | - |
? | |
3.4.15.1 | benzoyl-Gly-Phe-Arg + H2O | - |
Homo sapiens | benzoyl-Gly + Phe-Arg | - |
? | |
3.4.15.1 | bradykinin + H2O | - |
Homo sapiens | Phe-Arg + Ser-Pro + Arg-Pro-Pro-Gly-Phe | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.4.15.1 | monomer | 1 * 155000, enzyme from kidney and lung, SDS-PAGE in presence of 2-mercaptoethanol | Homo sapiens |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.15.1 | 76.7 | - |
benzoyl-Gly-His-Leu | - |
Homo sapiens | |
3.4.15.1 | 283 | - |
benzoyl-Gly-Gly-Gly | - |
Homo sapiens | |
3.4.15.1 | 383 | - |
benzoyl-Gly-Phe-Arg | - |
Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.15.1 | 6.5 | - |
at 0.1 M NaCl, substrate benzoyl-Gly-Gly-Gly | Homo sapiens |
3.4.15.1 | 7.6 | - |
at 1.0 mM NaCl, substrate benzoyl-Gly-Gly-Gly | Homo sapiens |